Literature DB >> 18587042

Prolonged survival of neutrophils from patients with Delta F508 CFTR mutations.

D J McKeon, A M Condliffe, A S Cowburn, K C Cadwallader, N Farahi, D Bilton, E R Chilvers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18587042     DOI： 10.1136/thx.2008.096834

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  29 in total

1.  The neutrophil-recruiting chemokine GCP-2/CXCL6 is expressed in cystic fibrosis airways and retains its functional properties after binding to extracellular DNA.

Authors:  S Jovic; H M Linge; M M Shikhagaie; A I Olin; L Lannefors; J S Erjefält; M Mörgelin; A Egesten
Journal:  Mucosal Immunol       Date:  2015-05-20       Impact factor: 7.313

Review 2.  Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.

Authors:  Laurent Meijer; Deborah J Nelson; Vladimir Riazanski; Aida G Gabdoulkhakova; Geneviève Hery-Arnaud; Rozenn Le Berre; Nadège Loaëc; Nassima Oumata; Hervé Galons; Emmanuel Nowak; Laetitia Gueganton; Guillaume Dorothée; Michaela Prochazkova; Bradford Hall; Ashok B Kulkarni; Robert D Gray; Adriano G Rossi; Véronique Witko-Sarsat; Caroline Norez; Frédéric Becq; Denis Ravel; Dominique Mottier; Gilles Rault
Journal:  J Innate Immun       Date:  2016-03-18       Impact factor: 7.349

3.  Critical role of CFTR-dependent lipid rafts in cigarette smoke-induced lung epithelial injury.

Authors:  Manish Bodas; Taehong Min; Neeraj Vij
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-03-04       Impact factor: 5.464

4.  Interaction with CREB binding protein modulates the activities of Nrf2 and NF-κB in cystic fibrosis airway epithelial cells.

Authors:  Assem G Ziady; Andrew Sokolow; Samuel Shank; Deborah Corey; Ross Myers; Scott Plafker; Thomas J Kelley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-30       Impact factor: 5.464

Review 5.  Resolvins: natural agonists for resolution of pulmonary inflammation.

Authors:  Mohib Uddin; Bruce D Levy
Journal:  Prog Lipid Res       Date:  2010-09-29       Impact factor: 16.195

Review 6.  Cystic fibrosis: a mucosal immunodeficiency syndrome.

Authors:  Taylor Sitarik Cohen; Alice Prince
Journal:  Nat Med       Date:  2012-04-05       Impact factor: 53.440

7.  Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers.

Authors:  Murali Shyamsundar; Scott T W McKeown; Cecilia M O'Kane; Thelma R Craig; Vanessa Brown; David R Thickett; Michael A Matthay; Clifford C Taggart; Janne T Backman; J Stuart Elborn; Daniel F McAuley
Journal:  Am J Respir Crit Care Med       Date:  2009-03-26       Impact factor: 21.405

8.  Myeloid CFTR loss-of-function causes persistent neutrophilic inflammation in cystic fibrosis.

Authors:  Hang Pong Ng; Scott Jennings; Dianne Wellems; Fei Sun; Jie Xu; William M Nauseef; Guoshun Wang
Journal:  J Leukoc Biol       Date:  2020-06-12       Impact factor: 4.962

9.  Absence of the cystic fibrosis transmembrane regulator (Cftr) from myeloid-derived cells slows resolution of inflammation and infection.

Authors:  T L Bonfield; C A Hodges; C U Cotton; M L Drumm
Journal:  J Leukoc Biol       Date:  2012-08-02       Impact factor: 4.962

10.  Modulation of Neutrophil Apoptosis and the Resolution of Inflammation through β2 Integrins.

Authors:  Driss El Kebir; János G Filep
Journal:  Front Immunol       Date:  2013-03-06       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.